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Abstract
Malignant peripheral nerve sheath tumours (MPNSTs) may occur in any peripheral nerve. They are often found in the chest wall and the
posterior mediastinum. On the other hand, primary pulmonary MPNST is extremely rare, and surgically treated cases have been reported.
Here, we present 3 cases of primary MPNST originating from the pulmonary parenchyma who underwent surgery in our institution. We
discuss the possible clinical and pathological associations in the view of the literature.
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INTRODUCTION
Malignant peripheral nerve sheath tumours (MPNSTs) are rare
soft-tissue sarcomas that develop within the peripheral nerve and
are often found in the chest wall and the posterior mediastinum.
However, primary pulmonary MPNST is extremely rare with only
scattered case reports in the English literature [1, 2]. In this report,
we present 3 patients with primary pulmonary MPNST.
CASE REPORTS
Patient 1
A 42-year old woman with a 27 pack-year smoking history was
admitted to our clinic with a 3-month history of mild dyspnoea.
Chest X-ray and computed tomography (CT) of the thorax revealed
a mass measuring 90 × 64 mm in the posterior segment of the right
upper lobe. Bronchoscopy was not diagnostic. CT-guided ﬁne-
needle biopsy was not diagnostic. Her forced expiratory volume in
one second (FEV1) was 1.6 l (58%). We performed a right upper
lobectomy and mediastinal lymph node dissection. The patient
recovered uneventfully and did not receive any adjuvant chemo-
radiotherapy. Microscopic examination revealed a highly vascular-
ized spindle cell tumour, prominent pleomorphism with giant cells
and atypical mitosis. Immunohistochemistry positively stained for
S-100 (focal), vimentin and desmin (Fig. 1), but was negative for
smooth muscle actin, CD34, BCL-2, EMA, CDK4 and myogenin. The
proliferation index of the tumour cells MIB-1 (Ki-67) was 80%. The
pathological diagnosis was MPNST. Twenty-ﬁve months following
the operation, she developed a second tumour in the lingula
portion of the left upper lobe. She underwent video-assisted thora-
coscopic surgery with wide resection of the lingula due to her
limited lung function. The diagnosis revealed adenocarcinoma of
the lung. She is alive and tumour free with a follow-up of 55 months.
Patient 2
A 66-year old heavy smoker (38 pack-year) male patient was ad-
mitted to our clinic with a 3-week history of dyspnoea. Chest
X-ray and thorax CT revealed a huge mass measuring 270 ×
220 mm in the right upper lobe (Fig. 2). Positron emission tomog-
raphy (PET) scan revealed a low standard uptake unit suggestive of
a sarcoma or a pleura tumour. Second CT-guided ﬁne-needle
biopsy demonstrated spindle cell malignant neoplasm. His FEV1
was 1.75 l (60%). He underwent extrapleural right pneumonec-
tomy via right hemi-clamshell incision. In the pathology report,
the bronchus and vascular structures (pulmonary artery and pul-
monary veins) were not invaded with the tumour. The pathologic-
al report revealed primary MPNST. The next day following the
operation, he transferred to the ward. On the ward, he developed
postoperative delirium. Due to inﬁltration on the left lung and in-
creasing respiratory problems, he transferred to the intensive care
unit (ICU). He also developed a fungal pneumonia. He was intu-
bated on the postoperative second day in the ICU and received
nitric oxide inhalation as well as Nova-Lung® due to unresponsive
hypercapnia. The patient died on the 22nd postoperative day.
Patient 3
A 67-year old ex-smoker (8 pack-year) male who had dizziness,
neck pain, nausea and vomiting underwent brain magnetic reson-
ance imaging (MRI) to rule out intracranial pathology. Brain MRI
showed a mass in cerebellum with compression of the fourth
ventricle with hydrocephalus. He underwent craniotomy with
the removal of the tumour. The pathological diagnosis of the
tumour was malignant high-grade pleomorphic and spindle cell
tumour with neurogenic differentiation. Immunohistochemistry
was focally positive for protein S-100, but negative for smooth
muscle actin and desmin. The proliferation rate MIB-1 was 60%.
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After craniotomy, he received cranial radiotherapy (25 Gy). PET
scan showed a lesion in the lingula portion of the left upper lobe.
He had an FEV1 of 4.56 l (135%). He underwent video-assisted tho-
racoscopic surgery left upper lobectomy with mediastinal lympha-
denectomy. The lung tumour showed the same morphology as the
cerebellum mass, favouring brain metastasis of a lung primary.
Immunohistochemistry showed strong S100 positive expression
and, focal expression of CKAE1 and CKAE3 (pan CKB). The tumour
cells were negative for melanoma markers HMB45, pan-Mmelan,
Melan A and tyrosinase as well as CD34, CD99, Synaptophysin and
TTF1. Reverse transcription polymerase chain reaction detected not
(12;22) translocation (EWSR1-ATF1 fusion), ruling out clear cell
sarcoma. Based on these ﬁndings, a diagnosis of MPNST was made.
He is alive without any signs of recurrent disease with a follow-up of
4 months.
DISCUSSION
Schwannomas can occur in any region of the thoracic cavity, but
are most frequently found in the posterior mediastinum and
costovertebral angle and are almost always associated with neuro-
ﬁbromatosis [2]. In the literature, rare cases with malignant
transformation of benign peripheral nerve sheath tumour were
reported. However, primary pulmonary schwannomas without
associated neuroﬁbromatosis can occur and are predominantly
benign with minimal tendency to recur [3]. Primary pulmonary
MPNST is uncommon and only 12 surgical case reports of this
tumour are available and those patients were treated with pneu-
monectomy, lobectomy or enucleation [4]. We performed a right
upper lobectomy in the ﬁrst case, a right pneumonectomy in the
second case and a left upper lobectomy in the third case in order
to achieve a complete resection.
Most peripheral MPNSTs are highly invasive and are associated
with a low survival rate; however, aggressive surgery signiﬁcantly
improves disease-free survival [4].We found no invasion to the thor-
acic wall in our cases. The ﬁrst case was free of recurrence 25
months after the operation, and then she developed a second
primary lung carcinoma. Currently, after 55 months of follow-up
she is alive without any sign of recurrent disease. The second case
died on the ICU due to acute respiratory distress following a right
pneumonectomy. The third case is alive without recurrence and is
under our follow-up. The radiographic feature of the tumour is a
round, ovoid or lobulated homogenous mass with sharp borders.
When the tumour is located proximal to the large bronchus, atelec-
tasis of the lung may be the only radiological sign and the symptoms
are presented as pneumonia cough and dyspnoea [3, 4]. In our
cases, there was a big round mass in the right and left upper lobes.
Primary intrapulmonary neurogenic tumours may be divided
histologically into neuroﬁbroma and neurilemmoma; neurogenic
sarcoma and malignant schwannoma are the malignant equi-
valents. In general, immunohistochemical staining detects S-100
protein in all schwannomas, but may be absent in malignant
nerve sheath tumour [4]. The utility of Ki-67, a tumour cell prolifer-
ation marker, has been reported in determining malignant poten-
tial. It has been shown that, in malignant nerve sheath tumours,
5–65% of the tumour cell nuclei were immunoreactive for Ki-67,
whereas none of the schwannomas had nuclear staining exceed-
ing 5% [1, 4]. In the ﬁrst case, an immunohistochemical study
revealed focal positivity for S-100 protein and proliferation index
of the tumour cells was 80%.
The use of neoadjuvant chemoradiotherapy followed by pneu-
monectomy with a long-term survival has been advocated [5].
These authors have concluded that the use of neoadjuvant che-
moradiotherapy to treat primary pulmonary sarcomas has poten-
tial beneﬁts over postoperative therapy or neoadjuvant radiation
therapy alone [5].
In conclusion, primary MPNSTs of the lungs are extremely rare
tumours and they are suitable for primary surgical resection.
Complete surgical resection provides both deﬁnitive diagnosis
and therapeutic option in these unique rare tumours.
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Figure 1: Highly vascularized spindle cell tumour, prominent pleomorphism
with giant cells and atypical mitosis. Immunoreactivity for protein S-100 (focal),
vimentin and desmin. Original magniﬁcations ×100× hematoxylin and eosin
stain and ×200 (immunohistochemistry)
Figure 2: The axial and coronal CT scans of the second case
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